• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

Harvard University — CRISPR-Based Diagnostics for Febrile Diseases

Visit Grantee Site
  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: Harvard University
  • Amount: $600,213

  • Award Date: December 2021

Table of Contents

    Open Philanthropy recommended a grant of $600,123 over two years to Harvard University to support research led by James Collins on developing CRISPR-based diagnostics for febrile (fever-inducing) diseases. Many deadly diseases such as malaria and typhoid fever cause similar fever symptoms but require targeted treatments, so improved diagnostics could have a large health impact — particularly since these would be designed for use in resource-limited settings in the developing world.

    This falls within our focus area of scientific research, and specifically within our interest in advancing human health and wellbeing.

    Related Items

    • Human Health and Wellbeing

      Yale University — Cardiovascular Research

      Open Philanthropy recommended a grant of $400,000 to Yale University to support research related to atherosclerosis, stroke, and cardiovascular function. This funding will go towards the purchase of...

      Read more
    • Human Health and Wellbeing

      University of Notre Dame — Biofilm-Resistant Catheters

      Open Philanthropy recommended a grant of $850,000 over three years to the University of Notre Dame to support work led by Professor Ana Flores-Mireles on developing a catheter design that...

      Read more
    • Human Health and Wellbeing

      Translational Health Science and Technology Institute — Henipavirus Antivirals

      Open Philanthropy recommended a grant of $1,020,475 over four years to the Translational Health Science and Technology Institute (THSTI). The THSTI is a government institute in the Department...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!